Darwin Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$87 – 1169
2026
Q2
$106 Hold
2
– – ﹤0.01% 664
2026
Q1
$120 Hold
2
– – ﹤0.01% 584
2025
Q4
$120 Hold
2
– – ﹤0.01% 635
2025
Q3
$117 Hold
2
– – ﹤0.01% 585
2025
Q2
$120 Hold
2
– – ﹤0.01% 586
2025
Q1
$120 Hold
2
– – ﹤0.01% 620
2024
Q4
$120 Hold
2
– – ﹤0.01% 620
2024
Q3
$144 Buy
+2
New +$108 ﹤0.01% 627
2020
Q2
– Sell
-2
Closed – – 671
2020
Q1
$0 Buy
+2
New +$96 ﹤0.01% 839

Other funds holding SNY

Darwin Wealth Management's SNY Position: Q3 2026 in Review

Darwin Wealth Management sold out of Sanofi (SNY) in Q3 2026, closing a stake of 2 shares — an estimated $87 sold.

Darwin Wealth Management first reported a position in SNY in Q1 2020 and held it in 9 quarters. The position peaked at $144 in Q3 2024. 436 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Darwin Wealth Management reported no remaining Sanofi position as of Q3 2026 after selling out during the quarter.
  • Darwin Wealth Management sold 2 Sanofi shares in Q3 2026, an estimated $87.
  • Darwin Wealth Management first reported a position in Sanofi in Q1 2020 and held it in 9 quarters.
  • Darwin Wealth Management's Sanofi position peaked at $144 in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.